1Turhan S ,Tnlunay C, Gulec S ,et al. The association between androgen levels and premature coronary artery disease in men[J]. Coron Artery Dis, 2007,18 (3) : 159-162.
2Marder W, Somers EC, Kaplan M J, et al. Effects of prasterone (dehydroe- piandrosterone) on markers of cardiovascular risk and bone turnover in premenopausal women with systemic lupus erythematosus :a pilot study[J]. Lupus, 2010,19 ( 10 ) : 1229-1236.
3Naessen T, Sjogren U, Bergquist J, et al. Endogenous steroids measured by high-specificity liquid chromatography-tandem mass spectrometry and prevalent cardiovascular disease in 70-year-old men and women[J]. J Clin Endocrinol Metab, 2010,95 (4) : 1889-1897.
4Srinath R, Hill Golden S, Carson KA, et al. Endogenous testosterone and its relationship to preclinical and clinical measures of cardiovascular dis- ease in the Atherosclerosis Risk in Communities (ARIC) Study[J]. J Clin Endocrinol Metab ,2015,100(4) : 1602-1608.
5Schatzl G, Masersbacher S,Temml C, et al. Serum androgen levels in men : impact of health status and age [J]. Urology, 2003,61 (3) : 629-633.
6PurneU JQ ,Bland LB ,Garzotto M ,et al. Effects of transdermal estrogen on levels of lipids ,lipase activity ,and inflammatory markers in men with pro- state cancer[J]. J Lipid Res, 2006,47 (2) : 349-355.
7Franeornano D, Bruzziches R, Natali M, et al. Cardiovascular effect of testosterone replacement therapy in aging male[J]. Aeta Biomed, 2010,81 Suppl 1 : 101-106.
8Arias-Santiago S, Gutirrrez-Salmer6n MT, Buend:a-Eisman A, et al. Lipid levels in women with androgenetic alopecia[J]. Int J Dermato1,2010, 49 ( 11 ) : 1340-1342.
9Yamagishi S. Role of advanced glyeation end products (AGE) and soluble receptor for AGE (sRAGE) in vascular complications in diabetes[J]. Nihon Rinsho, 2012,70 Suppl 5 : 243-247.
10Corona G, Mannucci E, Petrone L, et al. NECP-ATP lll-defined metabolic syndrome,type 2 diabetes mellitus,and prevalence of hypogonadism in male patients with sexual dysfunction[J]. J Sex Med,2007,4(g Pt 1 ) : 1038- 1045.
二级参考文献9
1Ross R.The pathogenesis of atherosclerosis:a perspective for the 1990s[J].Nature,1993,362:801 -809.
3Somjen D,Kohen F,Jaffe A,et al.Effects of gonadal steroids and their antagonists on DNA synthesis in human vascular cells[J].Hypertension,1998,32:39-45.
4Toshio H,Teiji E,Emiko M,et al.Dehydroepiandrosterone Retards Atherosclerosis Formation Through Its Conversion to Estrogen:The Possible Role of Nitric Oxide[J].Arterioscler Thromb Vase Biol,2000,20:782 -792.
5Williams M R,Ling S,Dawood T,et al.Dehydroepiandrosterone inhibits human vascular smooth muscle cell proliferation independent of ARs and ERs[J].J Clin Endocrinol Metab,2002,87 (1):176 -181.
6Yoneyama A,Kamiya Y,Kawaguchi M,et al.Effects of dehydroepiandrosterone on proliferation of human aortic smooth muscle cells[J].Life Sci,1997,60(11):833 -838.
7Dashtaki R,Whorton AR,Murphy Tm,et al.Dehydroepiandrosterone and analogs inhibit DNA binding of AP -1 and airway smooth muscle proliferation[J].J Pharmacol Exp Ther,1998,285(2):876 -883.
